RU2646486C2 - Композиции для медицинского устройства, содержащие бактериальные штаммы, которые продуцируют экзополисахариды совместно с камедями и/или желатинами - Google Patents
Композиции для медицинского устройства, содержащие бактериальные штаммы, которые продуцируют экзополисахариды совместно с камедями и/или желатинами Download PDFInfo
- Publication number
- RU2646486C2 RU2646486C2 RU2015104728A RU2015104728A RU2646486C2 RU 2646486 C2 RU2646486 C2 RU 2646486C2 RU 2015104728 A RU2015104728 A RU 2015104728A RU 2015104728 A RU2015104728 A RU 2015104728A RU 2646486 C2 RU2646486 C2 RU 2646486C2
- Authority
- RU
- Russia
- Prior art keywords
- streptococcus thermophilus
- thermophilus dsm
- dsm
- gum
- composition
- Prior art date
Links
- 230000001580 bacterial effect Effects 0.000 title claims abstract description 49
- 239000000203 mixture Substances 0.000 title claims abstract description 47
- 229920002444 Exopolysaccharide Polymers 0.000 title claims abstract description 35
- 108010010803 Gelatin Proteins 0.000 title description 20
- 229920000159 gelatin Polymers 0.000 title description 20
- 235000019322 gelatine Nutrition 0.000 title description 20
- 235000011852 gelatine desserts Nutrition 0.000 title description 20
- 241000194020 Streptococcus thermophilus Species 0.000 claims abstract description 65
- 230000000694 effects Effects 0.000 claims abstract description 22
- 210000001035 gastrointestinal tract Anatomy 0.000 claims abstract description 21
- 241000894006 Bacteria Species 0.000 claims abstract description 16
- 230000004888 barrier function Effects 0.000 claims abstract description 13
- 238000011065 in-situ storage Methods 0.000 claims abstract description 12
- 230000003232 mucoadhesive effect Effects 0.000 claims abstract description 8
- 239000003814 drug Substances 0.000 claims abstract description 6
- 230000002496 gastric effect Effects 0.000 claims abstract description 6
- 230000007170 pathology Effects 0.000 claims abstract description 5
- 230000002265 prevention Effects 0.000 claims abstract description 4
- 230000007812 deficiency Effects 0.000 claims abstract 2
- 238000004806 packaging method and process Methods 0.000 claims description 7
- 230000003843 mucus production Effects 0.000 claims description 3
- 210000004347 intestinal mucosa Anatomy 0.000 abstract description 7
- 210000003097 mucus Anatomy 0.000 abstract description 3
- 230000035899 viability Effects 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract description 2
- 238000004321 preservation Methods 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 description 22
- 241000196324 Embryophyta Species 0.000 description 21
- 239000006041 probiotic Substances 0.000 description 14
- 230000000529 probiotic effect Effects 0.000 description 14
- 235000018291 probiotics Nutrition 0.000 description 14
- 239000008273 gelatin Substances 0.000 description 13
- ZNOZWUKQPJXOIG-XSBHQQIPSA-L [(2r,3s,4r,5r,6s)-6-[[(1r,3s,4r,5r,8s)-3,4-dihydroxy-2,6-dioxabicyclo[3.2.1]octan-8-yl]oxy]-4-[[(1r,3r,4r,5r,8s)-8-[(2s,3r,4r,5r,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-sulfonatooxyoxan-2-yl]oxy-4-hydroxy-2,6-dioxabicyclo[3.2.1]octan-3-yl]oxy]-5-hydroxy-2-( Chemical compound O[C@@H]1[C@@H](O)[C@@H](OS([O-])(=O)=O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H]2OC[C@H]1O[C@H](O[C@H]1[C@H]([C@@H](CO)O[C@@H](O[C@@H]3[C@@H]4OC[C@H]3O[C@H](O)[C@@H]4O)[C@@H]1O)OS([O-])(=O)=O)[C@@H]2O ZNOZWUKQPJXOIG-XSBHQQIPSA-L 0.000 description 12
- 229920001938 Vegetable gum Polymers 0.000 description 11
- 229920002253 Tannate Polymers 0.000 description 9
- 239000000546 pharmaceutical excipient Substances 0.000 description 8
- 229920002907 Guar gum Polymers 0.000 description 7
- 235000010417 guar gum Nutrition 0.000 description 7
- 239000000665 guar gum Substances 0.000 description 7
- 229960002154 guar gum Drugs 0.000 description 7
- 240000006024 Lactobacillus plantarum Species 0.000 description 6
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 6
- 241000218588 Lactobacillus rhamnosus Species 0.000 description 6
- 235000011399 aloe vera Nutrition 0.000 description 6
- 244000052616 bacterial pathogen Species 0.000 description 6
- 229940072205 lactobacillus plantarum Drugs 0.000 description 6
- 230000009471 action Effects 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 210000000936 intestine Anatomy 0.000 description 5
- 240000007474 Aloe arborescens Species 0.000 description 4
- 235000004509 Aloe arborescens Nutrition 0.000 description 4
- 244000144927 Aloe barbadensis Species 0.000 description 4
- 235000002961 Aloe barbadensis Nutrition 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 210000001072 colon Anatomy 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 235000013311 vegetables Nutrition 0.000 description 4
- 239000002775 capsule Substances 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000003870 intestinal permeability Effects 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 241001116389 Aloe Species 0.000 description 2
- 206010070545 Bacterial translocation Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 230000007375 bacterial translocation Effects 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 108010063964 tannate gelatin Proteins 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 241000186016 Bifidobacterium bifidum Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 206010007134 Candida infections Diseases 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 241000206672 Gelidium Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 1
- 241000186673 Lactobacillus delbrueckii Species 0.000 description 1
- 241000186840 Lactobacillus fermentum Species 0.000 description 1
- 241000186684 Lactobacillus pentosus Species 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 229920002000 Xyloglucan Polymers 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 229940002008 bifidobacterium bifidum Drugs 0.000 description 1
- 239000003833 bile salt Substances 0.000 description 1
- 229940093761 bile salts Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 201000003984 candidiasis Diseases 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000012669 compression test Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 210000003495 flagella Anatomy 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 230000002178 gastroprotective effect Effects 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 210000003405 ileum Anatomy 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 1
- 229940012969 lactobacillus fermentum Drugs 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 244000005706 microflora Species 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000001819 pancreatic juice Anatomy 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000000770 proinflammatory effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 239000011885 synergistic combination Substances 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000010491 tara gum Nutrition 0.000 description 1
- 239000000213 tara gum Substances 0.000 description 1
- 230000009974 thixotropic effect Effects 0.000 description 1
- VLCQZHSMCYCDJL-UHFFFAOYSA-N tribenuron methyl Chemical compound COC(=O)C1=CC=CC=C1S(=O)(=O)NC(=O)N(C)C1=NC(C)=NC(OC)=N1 VLCQZHSMCYCDJL-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/238—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from seeds, e.g. locust bean gum or guar gum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/256—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from seaweeds, e.g. alginates, agar or carrageenan
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/275—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of animal origin, e.g. chitin
- A23L29/281—Proteins, e.g. gelatin or collagen
- A23L29/284—Gelatin; Collagen
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Inorganic Chemistry (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI2012A001328 | 2012-07-30 | ||
IT001328A ITMI20121328A1 (it) | 2012-07-30 | 2012-07-30 | Composizione per dispositivo medico comprendente ceppi di batteri produttori di esopolisaccaridi in associazione con gomme e/o gelatine. |
PCT/IB2013/001668 WO2014020408A1 (en) | 2012-07-30 | 2013-07-30 | Compositions for a medical device comprising exopolysaccharide-producing bacterial strains in association with gums and/or gelatines |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2015104728A RU2015104728A (ru) | 2016-09-20 |
RU2646486C2 true RU2646486C2 (ru) | 2018-03-05 |
Family
ID=46982688
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2015104728A RU2646486C2 (ru) | 2012-07-30 | 2013-07-30 | Композиции для медицинского устройства, содержащие бактериальные штаммы, которые продуцируют экзополисахариды совместно с камедями и/или желатинами |
Country Status (14)
Country | Link |
---|---|
US (2) | US9889166B2 (pl) |
EP (1) | EP2879685B1 (pl) |
KR (1) | KR20150038435A (pl) |
CN (1) | CN104540512A (pl) |
BR (1) | BR112015002054A2 (pl) |
CA (1) | CA2879014A1 (pl) |
DK (1) | DK2879685T3 (pl) |
ES (1) | ES2650455T3 (pl) |
IN (1) | IN2015MN00094A (pl) |
IT (1) | ITMI20121328A1 (pl) |
PL (1) | PL2879685T3 (pl) |
PT (1) | PT2879685T (pl) |
RU (1) | RU2646486C2 (pl) |
WO (1) | WO2014020408A1 (pl) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITMI20121328A1 (it) | 2012-07-30 | 2014-01-31 | Probiotical Spa | Composizione per dispositivo medico comprendente ceppi di batteri produttori di esopolisaccaridi in associazione con gomme e/o gelatine. |
CA2945631C (en) * | 2014-04-15 | 2023-04-11 | Novintethical Pharma Sa | Compositions based on xyloglucan and proteins for the treatment of intestinal disorders |
EP3145518B1 (en) | 2014-05-05 | 2021-02-17 | Probiotical S.p.A. | A composition comprising l. reuteri ler03 and l. salivarius ls06 for use in antiviral and antibacterial treating in a subject undergoing anti-tumor chemotherapy, leukemia treatment or aids therapy |
CA2967219A1 (en) * | 2014-11-26 | 2016-06-02 | Probiotical S.P.A. | Strains of lactobacillus or bifidobacterium for maintaining homeostasis |
ITUB20155700A1 (it) * | 2015-11-18 | 2017-05-18 | Probiotical Spa | Composizioni con azione sinergica tra un complesso gelificante muco-aderente contro il passaggio degli antigeni, e batteri immunomodulanti anti-IL17 per uso nel trattamento delle malattie autoimmuni e neurodegenerative IL17 dipendenti. |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002204669A (ja) * | 2001-01-11 | 2002-07-23 | Toyo Shinyaku:Kk | ケール加工物を含む便秘改善食品 |
CN101773221A (zh) * | 2010-01-21 | 2010-07-14 | 蜡笔小新(天津)有限公司 | 合生元果冻及其制作方法 |
RU2410423C2 (ru) * | 2005-10-11 | 2011-01-27 | Анидрал С.Р.Л. | Способ получения по меньшей мере одной неаллергенной пробиотической бактериальной культуры для изготовления пищевого продукта или фармацевтической композиции, предназначенных для лиц, пораженных целиакией и особенно чувствительных к аллергенным веществам глютенового и/или молочного типа (варианты) |
WO2011018547A1 (en) * | 2009-08-12 | 2011-02-17 | Vetcare Oy | Probiotic preparation for the prevention or treatment of canine gastrointestinal disorders |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005060937A1 (en) * | 2003-12-23 | 2005-07-07 | Chr. Hansen A/S | Compressed tablets comprising viable probiotic microorganisms |
EP2046352A4 (en) * | 2006-06-06 | 2012-03-21 | Univ Mcgill | FERMENTED MILK PRODUCT AND ITS USE |
CN101611738A (zh) * | 2008-06-26 | 2009-12-30 | 遵义市乳制品有限公司 | 双歧多益生菌多功能酸奶 |
CN102100252A (zh) * | 2009-12-18 | 2011-06-22 | 光明乳业股份有限公司 | 发酵乳制品及其制备方法和原料组合物,植物乳杆菌应用 |
MY149012A (en) * | 2010-03-29 | 2013-06-28 | Univ Putra Malaysia | Bioencapsule and method thereof |
ES2350436B1 (es) * | 2010-07-21 | 2011-11-28 | Fundacion Leia, C.D.T. | Material simbiotico microencapsulado |
ITMI20110934A1 (it) | 2011-05-24 | 2012-11-25 | Cohen Miguel Angel Alonso | Tannato di gelatina e sue associazioni per uso nel trattamento di malattie infiammatorie gastrointestinali |
CN102283334A (zh) * | 2011-08-31 | 2011-12-21 | 西华大学 | 可改善小型犬肠道微生态的复合益生菌微胶囊 |
ITRM20110477A1 (it) | 2011-09-09 | 2013-03-10 | Giovanni Mogna | Composizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell |
ITMI20121328A1 (it) | 2012-07-30 | 2014-01-31 | Probiotical Spa | Composizione per dispositivo medico comprendente ceppi di batteri produttori di esopolisaccaridi in associazione con gomme e/o gelatine. |
-
2012
- 2012-07-30 IT IT001328A patent/ITMI20121328A1/it unknown
-
2013
- 2013-07-30 KR KR1020157005091A patent/KR20150038435A/ko not_active Application Discontinuation
- 2013-07-30 CN CN201380040172.5A patent/CN104540512A/zh active Pending
- 2013-07-30 EP EP13777111.9A patent/EP2879685B1/en active Active
- 2013-07-30 CA CA2879014A patent/CA2879014A1/en not_active Abandoned
- 2013-07-30 DK DK13777111.9T patent/DK2879685T3/en active
- 2013-07-30 BR BR112015002054A patent/BR112015002054A2/pt not_active IP Right Cessation
- 2013-07-30 US US14/417,768 patent/US9889166B2/en not_active Expired - Fee Related
- 2013-07-30 WO PCT/IB2013/001668 patent/WO2014020408A1/en active Application Filing
- 2013-07-30 PT PT137771119T patent/PT2879685T/pt unknown
- 2013-07-30 PL PL13777111T patent/PL2879685T3/pl unknown
- 2013-07-30 RU RU2015104728A patent/RU2646486C2/ru active
- 2013-07-30 ES ES13777111.9T patent/ES2650455T3/es active Active
-
2015
- 2015-01-13 IN IN94MUN2015 patent/IN2015MN00094A/en unknown
-
2017
- 2017-12-20 US US15/848,812 patent/US20180133268A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002204669A (ja) * | 2001-01-11 | 2002-07-23 | Toyo Shinyaku:Kk | ケール加工物を含む便秘改善食品 |
RU2410423C2 (ru) * | 2005-10-11 | 2011-01-27 | Анидрал С.Р.Л. | Способ получения по меньшей мере одной неаллергенной пробиотической бактериальной культуры для изготовления пищевого продукта или фармацевтической композиции, предназначенных для лиц, пораженных целиакией и особенно чувствительных к аллергенным веществам глютенового и/или молочного типа (варианты) |
WO2011018547A1 (en) * | 2009-08-12 | 2011-02-17 | Vetcare Oy | Probiotic preparation for the prevention or treatment of canine gastrointestinal disorders |
CN101773221A (zh) * | 2010-01-21 | 2010-07-14 | 蜡笔小新(天津)有限公司 | 合生元果冻及其制作方法 |
Non-Patent Citations (1)
Title |
---|
Guzganu IL "Severe diarrhea in a 4-month-old baby girl with acute gastroenteritis: a case report and review of the literature", Case Rep Gastrointest Med. 2012; 2012:920375. doi: 10.1155/2012/920375. Epub 2012 Mar 25. стр.1-4. * |
Also Published As
Publication number | Publication date |
---|---|
PT2879685T (pt) | 2017-12-12 |
CN104540512A (zh) | 2015-04-22 |
EP2879685A1 (en) | 2015-06-10 |
ES2650455T3 (es) | 2018-01-18 |
EP2879685B1 (en) | 2017-09-20 |
DK2879685T3 (en) | 2017-12-11 |
US20180133268A1 (en) | 2018-05-17 |
US20150202239A1 (en) | 2015-07-23 |
CA2879014A1 (en) | 2014-02-06 |
WO2014020408A1 (en) | 2014-02-06 |
RU2015104728A (ru) | 2016-09-20 |
US9889166B2 (en) | 2018-02-13 |
IN2015MN00094A (pl) | 2015-10-16 |
KR20150038435A (ko) | 2015-04-08 |
PL2879685T3 (pl) | 2018-03-30 |
ITMI20121328A1 (it) | 2014-01-31 |
BR112015002054A2 (pt) | 2017-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11642386B2 (en) | Gold kiwifruit compositions and methods of preparation and use therefor | |
JP6444358B2 (ja) | ペディオコッカスを含有する医薬組成物および消化器症候群の症状を低減する方法 | |
Klayraung et al. | Development of tablets containing probiotics: Effects of formulation and processing parameters on bacterial viability | |
Qi et al. | Alginate-based double-network hydrogel improves the viability of encapsulated probiotics during simulated sequential gastrointestinal digestion: Effect of biopolymer type and concentrations | |
Sekhon et al. | Prebiotics, probiotics and synbiotics: an overview. | |
RU2646486C2 (ru) | Композиции для медицинского устройства, содержащие бактериальные штаммы, которые продуцируют экзополисахариды совместно с камедями и/или желатинами | |
Archer et al. | Anti-inflammatory potential of probiotic Lactobacillus spp. on carrageenan induced paw edema in Wistar rats | |
Bhat et al. | Improving survival of probiotic bacteria using bacterial poly-γ-glutamic acid | |
JP2014512376A (ja) | 胃酸過多症の薬理学的処置中に失われる胃のバリア効果を回復させることができるプロバイオティック細菌を含む組成物 | |
BR112012018813B1 (pt) | composição compreendendo cepas bacterianas com atividade anti-inflamatória, imunomoduladora, antiibs ou antidistensão abdominal, uso das mesmas, bem como produtos farmacêutico, veterinário e comestível compreendendo a referida composição | |
JP2014531430A (ja) | 胃酸過多の薬物処置中に失われる胃自体の障壁効果を修復することができるプロバイオティック細菌と組み合わされたn−アセチルシステインおよび/またはマイクロカプセル化胃保護型リゾチームを含む組成物 | |
Wang et al. | Effects of a novel encapsulating technique on the temperature tolerance and anti-colitis activity of the probiotic bacterium Lactobacillus kefiranofaciens M1 | |
Esmaeilzadeh et al. | Evaluation of the effect of psyllium on the viability of lactobacillus acidophilus in alginate-polyl lysine beads | |
Jang et al. | Encapsulation of probiotics with poly-γ-glutamic acid alters gut microbiota and short-chain fatty acid content by maintaining cell viability in the gastrointestinal tract | |
Zhang et al. | Construction of probiotic double-layered multinucleated microcapsules based on sulfhydryl-modified carboxymethyl cellulose sodium for increased intestinal adhesion of probiotics and therapy for intestinal inflammation induced by Escherichia coli O157: H7 | |
Huckle et al. | Maintenance and protection of probiotics | |
Kotikalapudi | Characterization and encapsulation of probiotic bacteria using a pea-protein alginate matrix | |
Kuate et al. | In Vitro Comparative Study of the Survival of Probiotic Capsules in a Simulated Gastric Environment | |
Mirzaeei et al. | Formulation direct compression tablet of probiotic as vehicle for oral delivery | |
Heidarrezaei et al. | Delivery of Probiotic-Loaded Microcapsules in the Gastrointestinal Tract: A Review | |
Chen | Development and evaluation of a novel probiotic delivery system |